Human plasma proteome analysis using chromatography, electrophoresis and mass spectrometry
The human plasma proteome is potentially rich in novel biomarkers for the diagnosis, prognosis of disease and drug development. In the quest for low abundant biomarkers, the problems associated with the complexity of sample and vast dynamic range in concentration have to be overcome. Such strategies...
| Main Author: | |
|---|---|
| Published: |
Queen Mary, University of London
2008
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.500312 |
| id |
ndltd-bl.uk-oai-ethos.bl.uk-500312 |
|---|---|
| record_format |
oai_dc |
| spelling |
ndltd-bl.uk-oai-ethos.bl.uk-5003122015-03-20T06:11:51ZHuman plasma proteome analysis using chromatography, electrophoresis and mass spectrometryBurn, Ross Thomas2008The human plasma proteome is potentially rich in novel biomarkers for the diagnosis, prognosis of disease and drug development. In the quest for low abundant biomarkers, the problems associated with the complexity of sample and vast dynamic range in concentration have to be overcome. Such strategies include the depletion of the most abundant proteins from plasma, the employment of prefractionation techniques and multidimensional separations. Mass spectrometry can be used to identify and quantify these biomarkers. The most abundant proteins can be depleted from plasma using antibody or dye based affinity columns. Several abundant protein depletion kits were investigated with the aim of selecting the most effective kit for subsequent analyses.612.01575Queen Mary, University of Londonhttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.500312Electronic Thesis or Dissertation |
| collection |
NDLTD |
| sources |
NDLTD |
| topic |
612.01575 |
| spellingShingle |
612.01575 Burn, Ross Thomas Human plasma proteome analysis using chromatography, electrophoresis and mass spectrometry |
| description |
The human plasma proteome is potentially rich in novel biomarkers for the diagnosis, prognosis of disease and drug development. In the quest for low abundant biomarkers, the problems associated with the complexity of sample and vast dynamic range in concentration have to be overcome. Such strategies include the depletion of the most abundant proteins from plasma, the employment of prefractionation techniques and multidimensional separations. Mass spectrometry can be used to identify and quantify these biomarkers. The most abundant proteins can be depleted from plasma using antibody or dye based affinity columns. Several abundant protein depletion kits were investigated with the aim of selecting the most effective kit for subsequent analyses. |
| author |
Burn, Ross Thomas |
| author_facet |
Burn, Ross Thomas |
| author_sort |
Burn, Ross Thomas |
| title |
Human plasma proteome analysis using chromatography, electrophoresis and mass spectrometry |
| title_short |
Human plasma proteome analysis using chromatography, electrophoresis and mass spectrometry |
| title_full |
Human plasma proteome analysis using chromatography, electrophoresis and mass spectrometry |
| title_fullStr |
Human plasma proteome analysis using chromatography, electrophoresis and mass spectrometry |
| title_full_unstemmed |
Human plasma proteome analysis using chromatography, electrophoresis and mass spectrometry |
| title_sort |
human plasma proteome analysis using chromatography, electrophoresis and mass spectrometry |
| publisher |
Queen Mary, University of London |
| publishDate |
2008 |
| url |
http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.500312 |
| work_keys_str_mv |
AT burnrossthomas humanplasmaproteomeanalysisusingchromatographyelectrophoresisandmassspectrometry |
| _version_ |
1716796049847222272 |